Monica Thomas - Jan 3, 2024 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
General Counsel
Signature
/s/ Monica Thomas
Stock symbol
GTHX
Transactions as of
Jan 3, 2024
Transactions value $
$0
Form type
4
Date filed
1/8/2024, 06:03 AM
Previous filing
May 24, 2023
Next filing
Mar 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Award $0 +28K +55.75% $0.00 78.2K Jan 3, 2024 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Options (Right to Buy) Award $0 +55.9K $0.00 55.9K Jan 3, 2024 Common Stock 55.9K $2.97 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award that vests 25% on January 3, 2025 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock.
F3 Represents (i) 176 shares of common stock; (ii) 50,000 RSUs from award granted on May 22, 2023; and (iii) 27,975 RSUs from award granted on January 3, 2024.
F4 The shares underlying this option vest as to 25% of the shares on January 3, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.